Avant Diagnostics, Inc. (OTCQB: AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company is seeking FDA approval of a test for early detection for pre-symptomatic ovarian cancer.

Biotechnology

Avant Diagnostics

Mick Ruxin

Mike Vallone

Claudius Mueller

Mattia Cremona

Trevor McCartney

The leadership team at Avant Diagnostics has a history of working in the oncology field for companies such as Theralink Technologies, Ashion, Natera, and Guardant Health. They also have experience in business development and sales for companies such as Metabolon, NanoString Technologies, and Bio-Rad Laboratories. They have degrees in fields such as public health management, political science, molecular and cellular biology, and biology.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Avant Diagnostics

Board of Directors

CEO and Executive Team